<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen X</submitter><funding>Natural Science Foundation of Guangdong Province, China</funding><funding>National Natural Science Foundation of China</funding><pagination>81</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10294458</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Dysregulation of lipid metabolism is closely associated with cancer progression. The study aimed to establish a prognostic model to predict distant metastasis-free survival (DMFS) in patients with nasopharyngeal carcinoma (NPC), based on lipidomics.&lt;h4>Methods&lt;/h4>The plasma lipid profiles of 179 patients with locoregionally advanced NPC (LANPC) were measured and quantified using widely targeted quantitative lipidomics. Then, patients were randomly split into the training (125 patients, 69.8%) and validation (54 patients, 30.2%) sets. To identify distant metastasis-associated lipids, univariate Cox regression was applied to the training set (P &lt; 0.05). A deep survival method called DeepSurv was employed to develop a proposed model based on significant lipid species (P &lt; </pubmed_abstract><journal>Lipids in health and disease</journal><pubmed_title>Widely targeted quantitative lipidomics and prognostic model reveal plasma lipid predictors for nasopharyngeal carcinoma.</pubmed_title><pmcid>PMC10294458</pmcid><funding_grant_id>81872375</funding_grant_id><funding_grant_id>82172863</funding_grant_id><funding_grant_id>31900461</funding_grant_id><funding_grant_id>2021A1515010118</funding_grant_id><pubmed_authors>Zhou JY</pubmed_authors><pubmed_authors>Zhang LL</pubmed_authors><pubmed_authors>Huang YY</pubmed_authors><pubmed_authors>Ke LR</pubmed_authors><pubmed_authors>Cai ZC</pubmed_authors><pubmed_authors>Guo X</pubmed_authors><pubmed_authors>Lv X</pubmed_authors><pubmed_authors>Zhan ZJ</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Liang CX</pubmed_authors><pubmed_authors>Cao X</pubmed_authors><pubmed_authors>Huang HY</pubmed_authors><pubmed_authors>Mei J</pubmed_authors><pubmed_authors>Xie GT</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Qiang MY</pubmed_authors><pubmed_authors>Li YX</pubmed_authors><pubmed_authors>Deng Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Widely targeted quantitative lipidomics and prognostic model reveal plasma lipid predictors for nasopharyngeal carcinoma.</name><description>&lt;h4>Background&lt;/h4>Dysregulation of lipid metabolism is closely associated with cancer progression. The study aimed to establish a prognostic model to predict distant metastasis-free survival (DMFS) in patients with nasopharyngeal carcinoma (NPC), based on lipidomics.&lt;h4>Methods&lt;/h4>The plasma lipid profiles of 179 patients with locoregionally advanced NPC (LANPC) were measured and quantified using widely targeted quantitative lipidomics. Then, patients were randomly split into the training (125 patients, 69.8%) and validation (54 patients, 30.2%) sets. To identify distant metastasis-associated lipids, univariate Cox regression was applied to the training set (P &lt; 0.05). A deep survival method called DeepSurv was employed to develop a proposed model based on significant lipid species (P &lt; </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jun</publication><modification>2025-04-26T04:49:02Z</modification><creation>2025-04-06T11:14:02.108Z</creation></dates><accession>S-EPMC10294458</accession><cross_references><pubmed>37365637</pubmed><doi>10.1186/s12944-023-01830-2</doi></cross_references></HashMap>